Furthermore, treatment with a SREBP inhibitor, fatostatin [16–18], inhibited cell growth and induced caspase-dependent apoptosis in metastatic AR-negative PCa cells, especially those harboring mutant p53s. Here, AR is linked to posterior cortical atrophy.